Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Pictet Asset Management SA

Pictet Asset Management SA decreased its stake in Henry Schein, Inc. (NASDAQ:HSICGet Rating) by 3.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 62,929 shares of the company’s stock after selling 2,383 shares during the period. Pictet Asset Management SA’s holdings in Henry Schein were worth $4,829,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in HSIC. American Century Companies Inc. lifted its stake in shares of Henry Schein by 23.6% in the first quarter. American Century Companies Inc. now owns 3,616,273 shares of the company’s stock valued at $315,303,000 after purchasing an additional 691,299 shares during the period. Pzena Investment Management LLC acquired a new stake in shares of Henry Schein in the first quarter valued at about $44,369,000. BlackRock Inc. lifted its stake in shares of Henry Schein by 3.5% in the first quarter. BlackRock Inc. now owns 12,609,559 shares of the company’s stock valued at $1,099,427,000 after purchasing an additional 427,442 shares during the period. Pendal Group Ltd lifted its stake in shares of Henry Schein by 12.6% in the second quarter. Pendal Group Ltd now owns 3,504,199 shares of the company’s stock valued at $268,912,000 after purchasing an additional 392,946 shares during the period. Finally, APG Asset Management N.V. lifted its stake in shares of Henry Schein by 111.1% in the first quarter. APG Asset Management N.V. now owns 608,795 shares of the company’s stock valued at $47,707,000 after purchasing an additional 320,357 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.

Henry Schein Price Performance

HSIC opened at $78.91 on Friday. The company’s 50 day simple moving average is $70.84 and its 200 day simple moving average is $75.73. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.00 and a current ratio of 1.84. Henry Schein, Inc. has a 1 year low of $64.75 and a 1 year high of $92.68. The stock has a market capitalization of $10.70 billion, a PE ratio of 17.15, a P/E/G ratio of 2.14 and a beta of 0.78.

Henry Schein announced that its board has initiated a stock buyback program on Thursday, August 18th that authorizes the company to repurchase $400.00 million in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the stock. William Blair restated a “market perform” rating on shares of Henry Schein in a report on Tuesday, November 1st. Credit Suisse Group dropped their target price on shares of Henry Schein from $100.00 to $90.00 and set an “outperform” rating for the company in a report on Wednesday, August 3rd. Evercore ISI dropped their target price on shares of Henry Schein to $83.00 in a report on Tuesday, August 9th. Barrington Research dropped their target price on shares of Henry Schein from $102.00 to $99.00 and set an “outperform” rating for the company in a report on Wednesday, August 3rd. Finally, Piper Sandler lowered their price target on shares of Henry Schein from $96.00 to $85.00 and set an “overweight” rating for the company in a report on Monday, September 26th. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $84.67.

Henry Schein Company Profile

(Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICGet Rating).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.